SCHEMBL26023253

SCHEMBL26023253

CC/C=C(/CNC(=O)OC(C)(C)C)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
CA12 O43570 4/20 0.35
CA1 P00915 4/20 0.35
CA2 P00918 4/20 0.35
CA14 Q9ULX7 2/20 0.35
CA7 P43166 2/20 0.35
CTSK P43235 4/20 0.35
CA9 Q16790 2/20 0.35
CTSS P25774 2/20 0.35
EPHX1 P07099 1/20 0.35
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21455250 0.79 MAOA (0.46) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL22374283 0.79 TDP1 (0.41) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL21455400 0.77 TDP1 (0.39) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL24311398 0.77 KMT2A (0.41) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL13223925 0.74 TDP1 (0.48) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL19575618 0.73 KMT2A (0.38) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL4714065 0.73 TDP1 (0.52) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL125503 0.73 TDP1 (0.52) TDP1MAOAMAOBKMT2AMEN1
SCHEMBL20909964 0.72 CA1 (0.35) TDP1KMT2AMEN1GAAALDH1A1
SCHEMBL16594495 0.72 TDP1 (0.47) TDP1MAOAMAOBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed